Expression of CYLD and NF-κB in human cholesteatoma epithelium

Mediators of Inflammation

Volumn 2010, Issue , 2010, Pages

  Byun, Jae Yong ^a   Yune, Tae Young ^b   Lee, Jee Youn ^b   Yeo, Seung Geun ^a   Park, Moon Suh ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYLD PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; CYLD PROTEIN, HUMAN;

ADULT; ARTICLE; BONE DESTRUCTION; CHOLESTEATOMA; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM HYPERPLASIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OTORRHEA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; EPITHELIUM; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

CHOLESTEATOMA, MIDDLE EAR; EPITHELIUM; HUMANS; MIDDLE AGED; NF-KAPPA B; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 77952514353     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2010/796315     Document Type: Article

References (19)

1. Courtois G., Tumor suppressor CYLD: negative regulation of NF-κB signaling and more Cellular and Molecular Life Sciences 2008 65 7-8 1123 1132
2. Miyao M., Shinoda H., Takahashi S., Caspase-3, caspase-8, and nuclear factor-B expression in human cholesteatoma Otology and Neurotology 2006 27 1 8 13
3. Zhang Q.-A., Hamajima Y., Zhang Q., Lin J., Identification of Id1 in acquired middle ear cholesteatoma Archives of Otolaryngology 2008 134 3 306 310
4. Karin M., How NF-κB is activated: the role of the I B kinase (IKK) complex Oncogene 1999 18 49 6867 6874
5. Kovalenko A., Chable-Bessia C., Cantarella G., Isral A., Wallach D., Courtois G., The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination Nature 2003 424 6950 801 805
6. Fukuda M., Hiroi M., Suzuki S., Ohmori Y., Sakashita H., Loss of CYLD might be associated with development of salivary gland tumors Oncology Reports 2008 19 6 1421 1427
7. Hellerbrand C., Bumes E., Bataille F., Dietmaier W., Massoumi R., Bosserhoff A. K., Reduced expression of CYLD in human colon and hepatocellular carcinomas Carcinogenesis 2007 28 1 21 27
8. Reiley W., Zhang M., Sun S.-C., Negative regulation of JNK signaling by the tumor suppressor CYLD Journal of Biological Chemistry 2004 279 53 55161 55167
9. Jin W., Chang M., Paul E. M., Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice Journal of Clinical Investigation 2008 118 5 1858 1866
10. Massoumi R., Chmielarska K., Hennecke K., Pfeifer A., Fssler R., Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-κB signaling Cell 2006 125 4 665 677
11. Weissman A. M., Themes and variations on ubiquitylation Nature Reviews Molecular Cell Biology 2001 2 3 169 178
12. Brummelkamp T. R., Nijman S. M. B., Dirac A. M. G., Bernards R., Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB Nature 2003 424 6950 797 801
13. Dajee M., Lazarov M., Zhang J. Y., NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia Nature 2003 421 6923 639 643
14. Seitz C. S., Deng H., Hinata K., Lin Q., Khavari P. A., Nuclear factor B subunits induce epithelial cell growth arrest Cancer Research 2000 60 15 4085 4092
15. Bell S., Degitz K., Quirling M., Jilg N., Page S., Brand K., Involvement of NF-κB signalling in skin physiology and disease Cell Signal 2003 15 1 1 7
16. Lizzul P. F., Aphale A., Malaviya R., Differential expression of phosphorylated NF-κB/RelA in normal and psoriatic epidermis and downregulation of NF-κB in response to treatment with etanercept Journal of Investigative Dermatology 2005 124 6 1275 1283
17. Abdou A. G., Hanout H. M., Evaluation of survivin and NF-κB in psoriasis, an immunohistochemical study Journal of Cutaneous Pathology 2008 35 5 445 451
18. Vasudevan K. M., Gurumurthy S., Rangnekar V. M., Suppression of PTEN expression by NF-κB prevents apoptosis Molecular and Cellular Biology 2004 24 3 1007 1021
19. Yune T. Y., Byun J. Y., Expression of PTEN and phosphorylated Akt in human cholesteatoma epithelium Acta Oto-Laryngologica 2009 129 5 501 506